Melanoma and Other Malignant Neoplasms of Skin Clinical Trial
Official title:
A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a History of Skin Cancer
This is a prospective, multicenter, sample collection study using DermTech's non-invasive skin collection kits to evaluate the mutation burden of non-lesional facial skin from subjects with a documented history of numerous basal cell carcinomas, squamous cell carcinomas or melanomas compared to that of subjects with no history of skin cancer matched for age, sex and Fitzpatrick phototype.
This is a prospective, multicenter, sample collection study using DermTech's non-invasive skin collection kits to evaluate the mutation burden of non-lesional facial skin from subjects with a documented history of numerous basal cell carcinomas, squamous cell carcinomas or melanomas compared to that of subjects with no history of skin cancer matched for age, sex and Fitzpatrick phototype. Approximately 20-30 participants will be enrolled in each of six (6) main groups outlined below for a total of 120-180 subjects and controls: ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03313492 -
Modifying Young Adult Skin Cancer Risk and Protective Behaviors
|
N/A | |
| Recruiting |
NCT03093909 -
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
|
Phase 1 | |
| Active, not recruiting |
NCT03131908 -
Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT02816021 -
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
|
Phase 2 |